Yellow fever vaccine - Crucell
Alternative Names: BERNA-YF; FlavimunLatest Information Update: 02 Oct 2021
At a glance
- Originator Berna Biotech
- Developer Crucell
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Yellow fever
Most Recent Events
- 25 Mar 2014 Discontinued - Phase-III for Yellow fever in Germany (SC)
- 25 Mar 2014 Discontinued - Preregistration for Yellow fever in Switzerland (SC)
- 22 Feb 2011 Crucell has been acquired by Johnson & Johnson